OMOM HD Capsule Endoscope

OMOM HD delivers Jinshan’s most advanced passive capsule endoscopy platform, featuring 512×512 pixel imaging (over 300% resolution improvement), 172-degree ultra-wide viewing angle, and AI-powered Vue Smart interpretation software that reduces reading time through automated redundancy deletion and lesion detection.

Product Overview

The OMOM HD system addresses the diagnostic challenge of small bowel visualization, a region largely inaccessible to conventional endoscopy. First-generation OMOM capsules launched in 2005 established Jinshan as China’s pioneer in wireless capsule endoscopy. The HD platform represents the culmination of nearly two decades of iterative development.

Clinical studies demonstrate diagnostic yields comparable to market-leading Given Imaging/Medtronic PillCam systems, with cost advantages positioning OMOM HD as an accessible alternative for emerging market healthcare systems.

Key Features

OMOM HD is a small bowel diagnostic platform by Jinshan, combining 512 × 512 imaging, a 172-degree viewing angle, and Vue Smart AI to flag 16 abnormality types automatically.

• High-Resolution Imaging: 512×512 pixel sensor delivers 300%+ resolution improvement over standard capsule endoscopes
• Ultra-Wide Viewing Angle: 172-degree field of view maximizes tissue coverage per captured frame
• SpeedSense Technology: Adaptive frame rate (2-10 FPS) automatically adjusts based on capsule transit speed
• Extended Battery Life: 12+ hours ensures complete small bowel transit even in patients with slow motility
• Vue Smart AI Platform: Machine learning algorithms delete up to 90% redundant images and automatically identify 16 types of abnormalities
• Two-Way RF Communication: Real-time adjustment of capture parameters during examination

Technical Specifications

OMOM HD is an FDA-cleared capsule by Jinshan, measuring 11.0 × 25.4 mm and weighing under 4 g, with 12-hour battery life and bidirectional RF communication.

Clinical Applications

The OMOM HD system is indicated for investigation of obscure gastrointestinal bleeding (OGIB), the primary application endorsed by ACG, ESGE, and JGES guidelines as first-line diagnostic modality.

Additional indications include evaluation of suspected small bowel tumors, inflammatory bowel disease (particularly Crohn’s disease with small bowel involvement), celiac disease monitoring, and assessment of NSAID-induced enteropathy.

Detection rates for small bowel pathology range from 45-76% depending on patient selection, with superior diagnostic yield in OGIB populations compared to patients presenting with non-specific abdominal symptoms.

Regulatory Status

OMOM capsule endoscopy systems entered the FDA-approved capsule endoscopy category alongside PillCam (Given Imaging), EndoCapsule (Olympus), and MiroCam (IntroMedic).

Frequently Asked Questions

How does OMOM HD compare to PillCam SB3?

Meta-analyses demonstrate no significant differences in diagnostic performance between major capsule endoscopy platforms. OMOM HD offers comparable image quality and detection rates with cost advantages, particularly relevant for healthcare systems in emerging markets where PillCam pricing limits accessibility.

How long does an OMOM HD examination take?

Patients swallow the capsule after overnight fasting and bowel preparation. The capsule transits the small bowel over 6-8 hours, with natural excretion typically within 24-48 hours. The Vue Smart software significantly reduces physician interpretation time through automated image processing.

What preparation is required for OMOM HD examination?

Standard preparation includes clear liquid diet the day before, 12-hour fasting, and ingestion of bowel preparation solution (typically mannitol and glucose saline) 4 hours before examination.